A BILL 
To amend part D of title XVIII of the Social Security 
Act to require the Secretary of Health and Human Serv-
ices to negotiate covered part D drug prices on behalf 
of Medicare beneficiaries. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Medicare Prescription 
4
Drug Price Negotiation Act of 2021’’. 
5
04:48 May 19, 2021
H2071
2 
•HR 2071 IH
SEC. 2. NEGOTIATION OF LOWER COVERED PART D DRUG 
1
PRICES ON BEHALF OF MEDICARE BENE-
2
FICIARIES. 
3
(a) NEGOTIATION BY SECRETARY.—Section 1860D– 
4
11 of the Social Security Act (42 U.S.C. 1395w–111) is 
5
amended by striking subsection (i) (relating to noninter-
6
ference) and inserting the following: 
7
‘‘(i) NEGOTIATION OF LOWER DRUG PRICES.— 
8
‘‘(1) IN GENERAL.—Notwithstanding any other 
9
provision of law, the Secretary shall negotiate with 
10
pharmaceutical manufacturers the prices (including 
11
discounts, rebates, and other price concessions) that 
12
may be charged to PDP sponsors and MA organiza-
13
tions for covered part D drugs for part D eligible in-
14
dividuals who are enrolled under a prescription drug 
15
plan or under an MA–PD plan. 
16
‘‘(2) 
NO
CHANGE
IN
RULES
FOR 
17
FORMULARIES.— 
18
‘‘(A) IN GENERAL.—Nothing in paragraph 
19
(1) shall be construed to authorize the Sec-
20
retary to establish or require a particular for-
21
mulary. 
22
‘‘(B) CONSTRUCTION.—Subparagraph (A) 
23
shall not be construed as affecting the Sec-
24
retary’s authority to ensure appropriate and 
25
adequate access to covered part D drugs under 
26
04:48 May 19, 2021
H2071
3 
•HR 2071 IH
prescription drug plans and under MA–PD 
1
plans, including compliance of such plans with 
2
formulary requirements under section 1860D– 
3
4(b)(3). 
4
‘‘(3) CONSTRUCTION.—Nothing in this sub-
5
section shall be construed as preventing the sponsor 
6
of a prescription drug plan, or an organization offer-
7
ing an MA–PD plan, from obtaining a discount or 
8
reduction of the price for a covered part D drug 
9
below the price negotiated under paragraph (1). 
10
‘‘(4) SEMI-ANNUAL REPORTS TO CONGRESS.— 
11
Not later than June 1, 2022, and every 6 months 
12
thereafter, the Secretary shall submit to the Com-
13
mittees on Ways and Means, Energy and Commerce, 
14
and Oversight and Government Reform of the House 
15
of Representatives and the Committee on Finance of 
16
the Senate a report on negotiations conducted by the 
17
Secretary to achieve lower prices for Medicare bene-
18
ficiaries, and the prices and price discounts achieved 
19
by the Secretary as a result of such negotiations.’’. 
20
(b) EFFECTIVE DATE.—The amendment made by 
21
subsection (a) shall take effect on the date of the enact-
22
ment of this Act and shall first apply to negotiations and 
23
prices for plan years beginning on January 1, 2022. 
24
Æ 
04:48 May 19, 2021
H2071
